A groundbreaking new type of cancer immunotherapy developed at the Icahn School of Medicine at Mount Sinai trains the innate
Continue reading »
Home »
Alexion Receives FDA Approval for New Advanced Formulation of Ultomiris (ravulizumab-cwvz) with Significantly Reduced Infusion Time
BOSTON–(BUSINESS WIRE)–Oct. 12, 2020– Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the U.S. Food and Drug Administration (FDA) has approved Ultomiris
Continue reading »
New approach to diagnosing genetic diseases using RNA sequencing increases yield
In the world of rare genetic diseases, exome and genome sequencing are two powerful tools used to make a diagnosis.
Continue reading »
New population of immune cells could play a role in multiple sclerosis
Multiple sclerosis (MS) is an autoimmune disorder that develops as immune cells attack the nervous system. T cells are a
Continue reading »
Germany reports record new virus cases in 24 hours
Germany recorded 11,287 new COVID-19 infections in 24 hours, a sharp jump from the previous day and a record for
Continue reading »
New Wave of COVID-19 Infections Taking Hold in America
WEDNESDAY, Oct. 21, 2020 — A third surge of COVID-19 cases now has a firm grip on the United States,
Continue reading »
Russia registers new Covid vaccine as cases hit record high
Credit: Pixabay/CC0 Public Domain President Vladimir Putin announced on Wednesday that Russia has registered its second coronavirus vaccine, while the
Continue reading »
New class of highly effective inhibitors protects against neurodegeneration
Neurobiologists at Heidelberg University have discovered how a special receptor at neuronal junctions that normally activates a protective genetic program
Continue reading »
New tools improve care for cancers that spread to the brain
Ambitious efforts at UVA Cancer Center to improve care delivered to patients with cancer that has spread to the brain
Continue reading »
New research challenges the most common model for diabetes research
Experimental models are key for understanding mechanistic aspects of diabetes and for developing better medicines. The probably most common diabetes
Continue reading »